The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

about

Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

P2860

Q39298376-909EEBD6-3976-484D-9716-2C70C06F56D2

P2860

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

Item

http://www.wikidata.org/entity/Q36438976

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@ast

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@en

type

Item

label

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@ast

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@en

prefLabel

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@ast

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@en

P1476

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

@en

P2093

Amy K Bei

http://www.w3.org/2001/XMLSchema#string

Boris E Shmukler

http://www.w3.org/2001/XMLSchema#string

Carlo Brugnara

http://www.w3.org/2001/XMLSchema#string

James R Mitchell

http://www.w3.org/2001/XMLSchema#string

Pedro Mejia

http://www.w3.org/2001/XMLSchema#string

Seth L Alper

http://www.w3.org/2001/XMLSchema#string

Venée N Tubman

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.

N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes

Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

The functional network of ion channels in T lymphocytes

Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies.

Functional significance of the intermediate conductance Ca2+-activated K+ channel for the short-term survival of injured erythrocytes.

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker se

Plasmodium falciparum: growth response to potassium channel blocking compounds.

P304

613-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01668-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manoj Duraisingh

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26459896

http://www.w3.org/2001/XMLSchema#string

P921

antimalarial

P932

4704178

http://www.w3.org/2001/XMLSchema#string

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

about

P2860

P2860

The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932